US-UK drug deal could result in 229,000 excess deaths in England, analysis suggests

Analysis reveals extent of impact on NHS of placating Donald Trump over price of British medicine exports The NHS will have to divert £45bn from essential services to pay for new medicines under the terms of the UK-US trade deal agreed last December, leading to more than 200,000 avoidable deaths of patients, analysis has found. Ministers have defended the deal as a way of helping British drug exports to the US avoid tariffs, and giving patients in England access to potentially life-extending drugs that would otherwise be denied. Continue reading...

This story was reported by Politics | The Guardian. EUROPES curates Europe's most relevant coverage — read the full report at the original source.